Newer approaches to androgen deprivation therapy in prostate cancer.
Pitts
W Reid
WR
D000726:Androgen Antagonists / Q000627:therapeutic use*; D000813:Anilides / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D004054:Diethylstilbestrol / Q000627:therapeutic use*; D004967:Estrogens / Q000097:blood; D006801:Humans; D008297:Male; D009570:Nitriles; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000517:prevention & control; D013739:Testosterone / Q000097:blood; D014105:Tosyl Compounds
D000726:Androgen Antagonists; D000813:Anilides; D018931:Antineoplastic Agents, Hormonal; D004967:Estrogens; D009570:Nitriles; D014105:Tosyl Compounds; D013739:Testosterone; D004054:Diethylstilbestrol; C053541:bicalutamide